ELTX – elicio therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer
Elicio Therapeutics: Running On Fumes, But A Definitive Readout Appears Imminent [Seeking Alpha]
Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC [Yahoo! Finance]
Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC
Elicio Therapeutics to Present Clinical and Preclinical Data at the SITC 2025 Annual Meeting
Form EFFECT Elicio Therapeutics,
Form SCHEDULE 13G/A Elicio Therapeutics, Filed by: Actyus Private Equity SGIIC, S.A.
Form 8-K Elicio Therapeutics, For: Sep 17
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.